Superior ophthalmic vein thrombosis in a patient with chronic myeloid leukemia receiving antifibrinolytic and thrombopoietin receptor agonist therapy

Roman Shinder, Patrick Oellers, Bita Esmaeli, Jade S. Schiffman

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Isolated superior ophthalmic vein (SOV) thrombosis is a rare condition usually related to inflammation of the orbit or paranasal sinuses.1-3 Patients present with acute orbital signs, including proptosis, ophthalmoplegia, globe dystopia, and periorbital edema, and may have diminished vision secondary to optic neuropathy. SOV thrombosis is typically seen in the setting of septic cavernous sinus thrombosis, and antimicrobial therapy is the treatment of choice. We herein report what may be the first case of isolated SOV thrombosis related to hypercoagulability in a patient with cancer who was receiving antifibrinolytic and thrombopoietin receptor agonist medications.

Original languageEnglish (US)
Pages (from-to)293-296
Number of pages4
JournalJournal of Ocular Pharmacology and Therapeutics
Volume26
Issue number3
DOIs
StatePublished - Jun 1 2010

ASJC Scopus subject areas

  • Ophthalmology
  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Superior ophthalmic vein thrombosis in a patient with chronic myeloid leukemia receiving antifibrinolytic and thrombopoietin receptor agonist therapy'. Together they form a unique fingerprint.

Cite this